Prescrire Int. 2014 Oct;23(153):234-5.
There is no firm evidence that lixisenatide prevents the clinical complications of diabetes. Given the many potentially serious adverse effects of incretin analogues of this type, the lack of benefit skews the balance towards greater harm.
